# Sodium Phosphates

NDC: 0409-7391
Generic name: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20050602

FDA application: NDA018892

## Active ingredients

- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS: 142 mg/mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 276 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-7391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-7391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f044d16-295e-43ff-72a3-b045c387bc5c